NEW YORK, Aug. 24, 2016 /PRNewswire/ -- The Law
Offices of Vincent Wong announce
that a class action lawsuit has been commenced in the USDC for the
District of New Jersey on behalf
of investors who purchased Insmed Incorporated (NASDAQ: INSM)
securities between March 18, 2013 and
June 8, 2016.
Click here to learn about the case:
http://www.wongesq.com/pslra/insmed-incorporated. There is
no cost or obligation to you.
According to the complaint, throughout the Class Period,
defendants issued false and misleading statements to investors
and/or failed to disclose that: (1) the data supporting Insmed's
European marketing authorization application ("MAA") for lead
product candidate ARIKAYCE was not likely to be approved by the
European Medicines Agency ("EMA") for the treatment of NTM lung
disease, and (2) therefore ARIKAYCE'S approval by the EMA and
subsequent commercialization in Europe were less likely and/or imminent than
Insmed led investors to believe.
On June 8, 2016, Insmed announced
it had withdrawn its MAA for ARIKAYCE from the EMA, revealing that
the Committee for Medicinal Products for Human Use indicated that
the phase 2 study did not provide a sufficient amount of evidence
to support an approval.
If you suffered a loss in Insmed you have until September 13, 2016 to request that the Court
appoint you as lead plaintiff. Your ability to share in any
recovery doesn't require that you serve as a lead plaintiff. To
obtain additional information, contact Vincent Wong, Esq. either via email
vw@wongesq.com, by telephone at 212.425.1140, or visit
http://www.wongesq.com/pslra/insmed-incorporated.
Vincent Wong, Esq. is an
experienced attorney that has represented investors in securities
litigations involving financial fraud and violations of shareholder
rights. Attorney advertising. Prior results do not guarantee
similar outcomes.
CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com
Logo - http://photos.prnewswire.com/prnh/20140904/143045
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/insm-investor-alert-the-law-offices-of-vincent-wong-notifies-investors-of-a-class-action-involving-insmed-incorporated-and-a-lead-plaintiff-deadline-of-september-13-2016-300317626.html
SOURCE The Law Offices of Vincent
Wong